These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26089925)

  • 1. Comparison of N-acetylcysteine and angiotensin converting enzyme inhibitors in blood pressure regulation in hypertensive patients.
    Khaledifar A; Mobasheri M; Kheiri S; Zamani Z
    ARYA Atheroscler; 2015 Jan; 11(1):5-13. PubMed ID: 26089925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetylcysteine potentiates the antihypertensive effect of ACE inhibitors in hypertensive patients.
    Barrios V; Calderón A; Navarro-Cid J; Lahera V; Ruilope LM
    Blood Press; 2002; 11(4):235-9. PubMed ID: 12361192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria.
    Kincaid-Smith P; Fairley K; Packham D
    Nephrol Dial Transplant; 2002 Apr; 17(4):597-601. PubMed ID: 11917051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual blockade of the renin-angiotensin system compared with a 50% increase in the dose of angiotensin-converting enzyme inhibitor: effects on proteinuria and blood pressure.
    Kincaid-Smith P; Fairley KF; Packham D
    Nephrol Dial Transplant; 2004 Sep; 19(9):2272-4. PubMed ID: 15252156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of one-year treatment by angiotensin converting enzyme inhibitor on baroreflex sensitivity and flow-mediated vasodilation of the brachial artery in essential hypertension--comparison with calcium channel blockers.
    Munakata M; Aihara A; Nunokawa T; Ito N; Imai Y; Ito S; Yoshinaga K
    Clin Exp Hypertens; 2003 Apr; 25(3):169-81. PubMed ID: 12716079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme inhibitors enhance the hypotensive effects of propofol by increasing nitric oxide production.
    Oliveira-Paula GH; Pinheiro LC; Ferreira GC; Garcia WNP; Lacchini R; Garcia LV; Tanus-Santos JE
    Free Radic Biol Med; 2018 Feb; 115():10-17. PubMed ID: 29138017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple vasopeptidase inhibition of angiotensin-converting enzyme/neutral endopeptidase/endothelin-converting enzyme activities on the hemodynamic profile of chronically instrumented unrestrained conscious spontaneously hypertensive rats.
    Daull P; Blouin A; Sirois P; Nantel F; Jeng AY; Battistini B
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S398-401. PubMed ID: 15838331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic Changes after Continuing or Omitting Regular Angiotensin Converting Enzyme Inhibitors before Cataract Surgery: A Comparative Study.
    Khademi S; Jouybar R; Ahmadi S; Asmarian N; Ghadimi M; Salari M; Emami S
    Curr Hypertens Rev; 2023; 19(1):59-65. PubMed ID: 36635901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers especially useful for cardiovascular protection?
    Ong HT
    J Am Board Fam Med; 2009; 22(6):686-97. PubMed ID: 19897698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of hospitalisation on the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in elderly hypertensive patients.
    Wawruch M; Slezakova V; Murin J; Luha J; Bozik M; Leitmann T; Kuzelova M; Shah R
    Aging Clin Exp Res; 2014 Jun; 26(3):307-14. PubMed ID: 24781831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative effects of angiotensin converting enzyme inhibitors and calcium antagonists on pulse pressure and blood pressure variability, based on ambulatory measurements in 236 mild to moderate hypertensive patients].
    Herpin D; Vaïsse B; Allavoine T; Pitiot M; de Gaudemaris R; Mallion JM; Poggi L; Demange J
    Arch Mal Coeur Vaiss; 1993 Aug; 86(8):1213-7. PubMed ID: 8129529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors in heart failure: physicians' prescribing behavior.
    Ferreira A; Bettencourt P; Cortez M; Araújo JP; Cerqueira-Gomes M
    J Card Fail; 1997 Dec; 3(4):295-302. PubMed ID: 9547444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study.
    Renke M; Tylicki L; Rutkowski P; Larczyński W; Aleksandrowicz E; Lysiak-Szydłowska W; Rutkowski B
    Kidney Blood Press Res; 2008; 31(6):404-10. PubMed ID: 19092257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade.
    Ferrari P; Marti HP; Pfister M; Frey FJ
    J Hypertens; 2002 Jan; 20(1):125-30. PubMed ID: 11791035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of the effects of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers on insulin sensitivity in hypertensive patients without diabetes.
    Yang Y; Wei RB; Wang ZC; Wang N; Gao YW; Li MX; Qiu Q
    Diabetes Res Clin Pract; 2015 Mar; 107(3):415-23. PubMed ID: 25649909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker on atrial natriuretic peptide.
    Sata N; Tanaka Y; Suzuki S; Kamimura R; Mifune H; Nakamura K; Miyahara K; Arima T
    Circ J; 2003 Dec; 67(12):1053-8. PubMed ID: 14639023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.